EPH161 Dose Escalation Patterns in Patients with Overweight or Obesity Initiating Semaglutide 2.4mg: A 6-Month Follow-up in a Real-World Setting in the United States
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.1043
https://www.valueinhealthjournal.com/article/S1098-3015(23)01143-9/fulltext
Title :
EPH161 Dose Escalation Patterns in Patients with Overweight or Obesity Initiating Semaglutide 2.4mg: A 6-Month Follow-up in a Real-World Setting in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)01143-9&doi=10.1016/j.jval.2023.03.1043
First page :
Section Title :
Open access? :
No
Section Order :
10490